- $17.20m
- $38.53m
- $36.03m
Annual cashflow statement for Orgenesis, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -26 | 0.579 | -18.1 | -12.2 | -64.9 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 5.72 | -76.8 | 4.73 | 5.25 | 11.9 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.99 | -1.9 | -15.4 | -19.9 | 36.6 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -13.2 | -78 | -26.9 | -24.9 | -14.8 |
| Capital Expenditures | -12.1 | -1.52 | -7.87 | -12.4 | -2.1 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -1.65 | 107 | -4.52 | -1.72 | -1.61 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -13.8 | 106 | -12.4 | -14.1 | -3.71 |
| Financing Cash Flow Items | 13.2 | — | — | 20.6 | 5 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 24.1 | 5.88 | -0.106 | 39.6 | 13.6 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2.96 | 33.5 | -39.6 | 0.395 | -4.89 |